{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:53:48Z","timestamp":1794646428413,"version":"4.9.1"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.biopha.2025.118315","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:07:33Z","timestamp":1751537253000},"page":"118315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Cardioprotective strategies against doxorubicin-induced cardiotoxicity: A review from standard therapies to emerging mitochondrial transplantation"],"prefix":"10.1016","volume":"189","author":[{"given":"Kanako","family":"Ito-Hagiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance B.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-3318","authenticated-orcid":false,"given":"Kei","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118315_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer Journal Clinicians"},{"key":"10.1016\/j.biopha.2025.118315_bib2","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200011093431901","article-title":"Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents","volume":"343","author":"Esteller","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib3","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1200\/JCO.2006.06.5391","article-title":"Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer","volume":"24","author":"Jones","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.118315_bib4","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1200\/JCO.2001.19.14.3312","article-title":"Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan","volume":"19","author":"Gordon","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.118315_bib5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.bjc.6604480","article-title":"Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer","volume":"99","author":"Baka","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118315_bib6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1200\/JCO.2012.43.4803","article-title":"Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)","volume":"31","author":"Gordon","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.118315_bib7","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1200\/JCO.2014.60.0734","volume":"33","author":"Bielack","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.118315_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1007094214460","article-title":"Adriamycin-induced heart failure: mechanisms and modulation","volume":"207","author":"Pawan","year":"2000","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2025.118315_bib9","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1158\/0008-5472.CAN-07-1649","article-title":"Topoisomerase II\u03b2\u2013Mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane","volume":"67","author":"Lyu","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2025.118315_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","article-title":"Molecular mechanism of doxorubicin-induced cardiomyopathy \u2013 An update","volume":"818","author":"Renu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118315_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.biopha.2018.06.161","article-title":"Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis","volume":"106","author":"Kuzu","year":"2018","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118315_bib12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2025.118315_bib13","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118315_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/157340311799960681","article-title":"Management of chemotherapy induced cardiomyopathy","volume":"7","author":"Saidi","year":"2011","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.biopha.2025.118315_bib15","first-page":"771","article-title":"Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin","volume":"61","author":"Zhou","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.118315_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107790","article-title":"Mitochondrial transplantation ameliorates doxorubicin-induced cardiac dysfunction via activating glutamine metabolism","volume":"26","author":"Sun","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.biopha.2025.118315_bib17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/157340311799960645","article-title":"3rd. Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment","volume":"7","author":"Volkova","year":"2011","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.biopha.2025.118315_bib18","article-title":"A biophysical systems approach to identifying the pathways of acute and chronic doxorubicin mitochondrial cardiotoxicity","volume":"12","author":"Beard","year":"2016","journal-title":"PLOS Comput. Biol."},{"key":"10.1016\/j.biopha.2025.118315_bib19","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.169756","article-title":"Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity","volume":"8","author":"Tadokoro","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2025.118315_bib21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI72931","article-title":"Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation","volume":"124","author":"Ichikawa","year":"2014","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2025.118315_bib22","doi-asserted-by":"crossref","first-page":"53272","DOI":"10.1074\/jbc.M406879200","article-title":"Doxorubicin Activates ATM-dependent Phosphorylation of Multiple Downstream Targets in Part through the Generation of Reactive Oxygen Species","volume":"279","author":"Kurz","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118315_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCULATIONAHA.108.799700","article-title":"Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway","volume":"119","author":"Zhu","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118315_bib24","doi-asserted-by":"crossref","first-page":"25535","DOI":"10.1074\/jbc.M400944200","article-title":"Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms","volume":"279","author":"Wang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118315_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2022.183984","article-title":"Cardiolipin nanodisks confer protection against doxorubicin-induced mitochondrial dysfunction","volume":"1864","author":"Fox","year":"2022","journal-title":"Biochim. Et. Biophys. Acta (BBA) Biomembr."},{"key":"10.1016\/j.biopha.2025.118315_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaccao.2021.08.001","article-title":"Combat doxorubicin cardiotoxicity with the power of mitochondria transfer","volume":"3","author":"Wang","year":"2021","journal-title":"JACC CardioOncol."},{"key":"10.1016\/j.biopha.2025.118315_bib27","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118315_bib28","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2025.118315_bib29","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1006\/bbrc.1993.2135","article-title":"A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity","volume":"195","author":"Adachi","year":"1993","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2025.118315_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0005-2728(99)00011-0","article-title":"Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration","volume":"1411","author":"Serrano","year":"1999","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2025.118315_bib31","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1158\/1078-0432.CCR-13-3373","article-title":"Mitochondrial topoisomerase I (Top1mt) is a novel limiting factor of doxorubicin cardiotoxicity","volume":"20","author":"Khiati","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118315_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/nu9090966","article-title":"Antioxidant therapeutic strategies for cardiovascular conditions associated with oxidative stress","volume":"9","author":"Far\u00edas","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2025.118315_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1521020","article-title":"Oxidative stress and cellular response to doxorubicin: a common factor in the complex milieu of anthracycline cardiotoxicity","volume":"2017","author":"Cappetta","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2025.118315_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2025.118315_bib35","doi-asserted-by":"crossref","first-page":"760","DOI":"10.7150\/ijbs.65258","article-title":"Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death","volume":"18","author":"Kong","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2025.118315_bib36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.redox.2017.12.013","article-title":"MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2","volume":"15","author":"Zhao","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118315_bib37","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1128\/MCB.00426-08","article-title":"SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70","volume":"28","author":"Sundaresan","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118315_bib38","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.18632\/aging.102418","article-title":"PGC1\u03b1 activation by pterostilbene ameliorates acute doxorubicin cardiotoxicity by reducing oxidative stress via enhancing AMPK and SIRT1 cascades","volume":"11","author":"Liu","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.biopha.2025.118315_bib39","doi-asserted-by":"crossref","first-page":"H962","DOI":"10.1152\/ajpheart.00832.2015","article-title":"Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice","volume":"310","author":"Pillai","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.118315_bib40","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00204-015-1583-9","article-title":"p66Shc signaling is involved in stress responses elicited by anthracycline treatment of rat cardiomyoblasts","volume":"90","author":"Sampaio","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2025.118315_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/3832648","article-title":"Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1\/p66Shc-Mediated Pathway","volume":"2019","author":"Wu","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2025.118315_bib42","article-title":"Activation of miR-34a-5p\/Sirt1\/p66shc pathway contributes to doxorubicin-induced cardiotoxicity","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118315_bib43","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bbrc.2019.10.157","article-title":"MiR-124 attenuates doxorubicin-induced cardiac injury via inhibiting p66Shc-mediated oxidative stress","volume":"521","author":"Liu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2025.118315_bib44","article-title":"Deficiency in cardiolipin reduces doxorubicin-induced oxidative stress and mitochondrial damage in human B-lymphocytes","volume":"11","author":"Mukhopadhyay","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2025.118315_bib45","doi-asserted-by":"crossref","first-page":"H1466","DOI":"10.1152\/ajpheart.00795.2008","article-title":"Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro","volume":"296","author":"Mukhopadhyay","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.118315_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109547","article-title":"Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling","volume":"122","author":"Qi","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118315_bib47","doi-asserted-by":"crossref","first-page":"34082","DOI":"10.18632\/oncotarget.16133","article-title":"Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice","volume":"8","author":"Pillai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118315_bib48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jjcc.2022.01.001","article-title":"The effects of doxorubicin on cardiac calcium homeostasis and contractile function","volume":"80","author":"Shinlapawittayatorn","year":"2022","journal-title":"J. Cardiol."},{"key":"10.1016\/j.biopha.2025.118315_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.toxlet.2017.04.010","article-title":"Salvianolic acid B attenuates doxorubicin-induced ER stress by inhibiting TRPC3 and TRPC6 mediated Ca(2+) overload in rat cardiomyocytes","volume":"276","author":"Chen","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2025.118315_bib50","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/mol.114.093849","article-title":"Adverse effects of doxorubicin and its metabolic product on cardiac RyR2 and SERCA2A","volume":"86","author":"Hanna","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118315_bib51","doi-asserted-by":"crossref","first-page":"11389","DOI":"10.1073\/pnas.1513047112","article-title":"Mitochondrial calcium overload is a key determinant in heart failure","volume":"112","author":"Santulli","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118315_bib52","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.yjmcc.2008.12.022","article-title":"Local control of mitochondrial membrane potential, permeability transition pore and reactive oxygen species by calcium and calmodulin in rat ventricular myocytes","volume":"46","author":"Odagiri","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2025.118315_bib53","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1172\/JCI43171","article-title":"Cyclophilin D controls mitochondrial pore\u2013dependent Ca2+ exchange, metabolic flexibility, and propensity for heart failure in mice","volume":"120","author":"Elrod","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2025.118315_bib54","doi-asserted-by":"crossref","first-page":"R227","DOI":"10.1152\/ajpregu.00299.2019","article-title":"Doxorubicin-induced oxidative stress differentially regulates proteolytic signaling in cardiac and skeletal muscle","volume":"318","author":"Montalvo","year":"2020","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.biopha.2025.118315_bib55","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1101\/gad.992302","article-title":"ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats","volume":"16","author":"Nishitoh","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2025.118315_bib56","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/BJ20050285","article-title":"Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium","volume":"389","author":"Kalivendi","year":"2005","journal-title":"Biochem J."},{"key":"10.1016\/j.biopha.2025.118315_bib57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.mam.2005.07.010","article-title":"Iron and copper metabolism","volume":"26","author":"Arredondo","year":"2005","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408360701713104","article-title":"Oxidative Stress and Iron Homeostasis: Mechanistic and Health Aspects","volume":"45","author":"Galaris","year":"2008","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.biopha.2025.118315_bib59","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.biopha.2025.118315_bib60","first-page":"8422","article-title":"Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy","volume":"61","author":"Minotti","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.118315_bib61","doi-asserted-by":"crossref","first-page":"16263","DOI":"10.1073\/pnas.0904519106","article-title":"Abcb10 physically interacts with mitoferrin-1 (Slc25a37) to enhance its stability and function in the erythroid mitochondria","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118315_bib62","article-title":"A novel role of p53 in regulating cellular iron metabolism through ISCU and FDXR","volume":"37","author":"Zhang","year":"2017","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2025.118315_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003408","article-title":"Iron-responsive miR-485-3p regulates cellular iron homeostasis by targeting ferroportin","volume":"9","author":"Sangokoya","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.biopha.2025.118315_bib64","first-page":"281","article-title":"The mitochondrial transporter ABCB8 protects against cardiomyopathy induced by doxorubicin","volume":"16","author":"Shan","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib65","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4103\/1673-5374.385313","article-title":"Mitochondrial transplantation confers protection against the effects of ischemic stroke by repressing microglial pyroptosis and promoting neurogenesis","volume":"19","author":"Sun","year":"2024","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.biopha.2025.118315_bib66","first-page":"614","article-title":"p53 mediates ferroptosis by regulating SLC7A11","volume":"23","author":"Wang","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2025.118315_bib67","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.bbamcr.2008.05.027","article-title":"Glutathione peroxidase 1-deficient mice are more susceptible to doxorubicin-induced cardiotoxicity","volume":"1783","author":"Gao","year":"2008","journal-title":"Biochimica et Biophysica Acta (BBA) Molecular Cell Research"},{"key":"10.1016\/j.biopha.2025.118315_bib68","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0002-9440(10)65036-5","article-title":"Immunocytochemical localization of metallothionein and its relation to doxorubicin toxicity in transgenic mouse heart","volume":"156","author":"Zhou","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2025.118315_bib69","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Friedmann Angeli","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118315_bib70","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2117396119","article-title":"Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis and contributes to doxorubicin-induced cardiomyopathy","volume":"119","author":"Ta","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118315_bib71","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s41418-022-00990-5","article-title":"PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2\/GPX4 pathway","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2025.118315_bib72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41401-024-01367-9","article-title":"Asiatic acid ameliorates doxorubicin-induced cardiotoxicity by promoting FPN-mediated iron export and inhibiting ferroptosis","volume":"46","author":"Wu","year":"2025","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2025.118315_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123379","article-title":"Metallothionein rescues doxorubicin cardiomyopathy via mitigation of cuproptosis","volume":"363","author":"Liu","year":"2025","journal-title":"Life Sci."},{"issue":"A","key":"10.1016\/j.biopha.2025.118315_bib74","first-page":"A17","article-title":"Cell death in heart failure","volume":"72","author":"Nishida","year":"2008","journal-title":"Circulation journal official journal Japanese Circulation Society"},{"key":"10.1016\/j.biopha.2025.118315_bib75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the Pathogenesis of Disease","volume":"132","author":"Levine","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118315_bib76","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.RES.0000261924.76669.36","article-title":"Distinct roles of autophagy in the heart during ischemia and reperfusion","volume":"100","author":"Matsui","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118315_bib77","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1101\/gad.215871.113","article-title":"Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure","volume":"27","author":"Thomas","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2025.118315_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101523","article-title":"NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy","volume":"34","author":"Zeng","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118315_bib79","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-020-01595-x","article-title":"TFEB-NF-\u03baB inflammatory signaling axis: a novel therapeutic pathway of Dihydrotanshinone I in doxorubicin-induced cardiotoxicity","volume":"39","author":"Wang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118315_bib80","article-title":"Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-\u03b1 and VEGF pathway in progressive of cardiovascular damage","volume":"76","author":"Syukri","year":"2022","journal-title":"Ann. Med Surg. (Lond. )"},{"key":"10.1016\/j.biopha.2025.118315_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202412017","article-title":"Mitochondrial amount determines doxorubicin-induced cardiotoxicity in cardiomyocytes","volume":"12","author":"Xiong","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2025.118315_bib82","article-title":"Mitochondrial-targeted therapy for doxorubicin-induced cardiotoxicity","volume":"23","author":"Wu","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118315_bib83","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.immuni.2020.02.002","article-title":"mtDNA activates cGAS signaling and suppresses the YAP-mediated endothelial cell proliferation program to promote inflammatory injury","volume":"52","author":"Huang","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2025.118315_bib84","article-title":"Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118315_bib85","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.2147\/DDDT.S469331","article-title":"Cardiotoxicity of anticancer drugs: molecular mechanisms, clinical management and innovative treatment","volume":"18","author":"Gao","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.biopha.2025.118315_bib86","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2590676","article-title":"Apigenin attenuates adriamycin-induced cardiomyocyte apoptosis via the PI3K\/AKT\/mTOR pathway","author":"Yu","year":"2017","journal-title":"Evid. Based Complement. Altern. Med. 2017"},{"key":"10.1016\/j.biopha.2025.118315_bib87","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01077-5","article-title":"Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy","volume":"21","author":"Shi","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.biopha.2025.118315_bib88","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/jpp\/rgac063","article-title":"Doxorubicin-induced cardiotoxicity: causative factors and possible interventions","volume":"74","author":"Jones","year":"2022","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118315_bib89","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib90","first-page":"412","article-title":"Mitochondrial transplantation: opportunities and challenges","volume":"16","author":"Picard","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2025.118315_bib91","first-page":"56","article-title":"Mitochondrial transplantation attenuates doxorubicin-induced cardiotoxicity via rescue of mitochondrial function","volume":"157","author":"Park","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2025.118315_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115651","article-title":"Allogeneic mitochondrial transplantation ameliorates cardiac dysfunction due to doxorubicin: an in vivo study","volume":"168","author":"Maleki","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118315_bib93","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s10741-023-10328-z","article-title":"ACEI\/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breast cancer: a systematic review and meta-analysis","volume":"28","author":"Gao","year":"2023","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.biopha.2025.118315_bib94","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tips.2022.10.003","article-title":"Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity","volume":"44","author":"Wu","year":"2023","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118315_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00113","article-title":"Luteolin attenuates doxorubicin-induced cardiotoxicity through promoting mitochondrial autophagy","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2025.118315_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114743","article-title":"Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics","volume":"192","author":"Arinno","year":"2021","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118315_bib97","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1200\/JCO.22.02423","article-title":"Dexrazoxane and long-term heart function in survivors of childhood cancer","volume":"41","author":"Chow","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.118315_bib98","doi-asserted-by":"crossref","unstructured":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. The Lancet, 1999, 353:pp. 9-13. doi: 10.1016\/s0140-6736(98)11181-9.","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"10.1016\/j.biopha.2025.118315_bib99","doi-asserted-by":"crossref","unstructured":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF). The Lancet, 1999, 353:2001-2007. doi: 10.1016\/s0140-6736(99)04440-2.","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"10.1016\/j.biopha.2025.118315_bib100","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib101","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118315_bib102","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118315_bib103","doi-asserted-by":"crossref","unstructured":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The New England journal of medicine, 1987, 316: pp.1429-1435. doi: 10.1056\/nejm198706043162301.","DOI":"10.1056\/NEJM198706043162301"},{"key":"10.1016\/j.biopha.2025.118315_bib104","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.acvd.2014.01.010","article-title":"Heart failure with systolic dysfunction complicating acute myocardial infarction \u2013 differential outcomes but similar eplerenone efficacy by ST-segment or non-ST-segment elevation: a post hoc substudy of the EPHESUS trial","volume":"107","author":"Carillo","year":"2014","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.biopha.2025.118315_bib106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib107","first-page":"709","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"Random Aldactone Eval. Study Invest. N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib108","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1161\/CIRCULATIONAHA.106.630194","article-title":"Statins Activate AMP-activated protein kinase in vitro and in vivo","volume":"114","author":"Sun","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118315_bib109","doi-asserted-by":"crossref","first-page":"14734","DOI":"10.1074\/jbc.M808664200","article-title":"Regulation of Rac1 by Simvastatin in Endothelial Cells","volume":"284","author":"Kou","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118315_bib110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10557-020-06941-x","article-title":"The role of AMPK activation for cardioprotection in doxorubicin-induced cardiotoxicity","volume":"34","author":"Timm","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.biopha.2025.118315_bib111","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial determinants of doxorubicin-induced cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118315_bib112","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1186\/1471-2407-14-842","article-title":"Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms","volume":"14","author":"Deng","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2025.118315_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.863314","article-title":"Novel therapeutics for anthracycline induced cardiotoxicity","volume":"9","author":"Vuong","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib114","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/CS20110069","article-title":"Doxorubicin-induced cardiac dysfunction is attenuated by ciclosporin treatment in mice through improvements in mitochondrial bioenergetics","volume":"121","author":"Marechal","year":"2011","journal-title":"Clin. Sci. (Lond. )"},{"key":"10.1016\/j.biopha.2025.118315_bib115","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1128\/MCB.00911-10","article-title":"Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytes","volume":"31","author":"Papanicolaou","year":"2023","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2025.118315_bib116","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/gb-2004-5-5-224","article-title":"Sirtuins: Sir2-related NAD-dependent protein deacetylases","volume":"5","author":"North","year":"2004","journal-title":"Genome Biol."},{"key":"10.1016\/j.biopha.2025.118315_bib117","first-page":"144","article-title":"Resveratrol in prostate diseases - a short review","volume":"66","author":"Jasi\u0144ski","year":"2013","journal-title":"Cent. Eur. J. Urol."},{"key":"10.1016\/j.biopha.2025.118315_bib118","article-title":"Luteolin attenuates doxorubicin-induced cardiotoxicity by modulating the PHLPP1\/AKT\/Bcl-2 signalling pathway","volume":"8","author":"Zhang","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.biopha.2025.118315_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104846","article-title":"Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission","volume":"157","author":"Liang","year":"2020","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.118315_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051184","article-title":"The cardioprotective effect of metformin in doxorubicin-induced cardiotoxicity: the role of autophagy","volume":"23","author":"Zilinyi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118315_bib121","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2018.08.032","article-title":"AMPK\/PGC1\u03b1 activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis","volume":"129","author":"Liu","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib122","article-title":"Metformin protects cardiomyocyte from doxorubicin induced cytotoxicity through an AMP-activated protein kinase dependent signaling pathway: an in vitro study","volume":"9","author":"L\u00f3pez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118315_bib123","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/jpi.12176","article-title":"Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin","volume":"57","author":"Govender","year":"2014","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.biopha.2025.118315_bib124","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2017.06.003","article-title":"LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy","volume":"108","author":"Xia","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2025.118315_bib125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.freeradbiomed.2017.08.010","article-title":"Ellagic acid antagonizes Bnip3-mediated mitochondrial injury and necrotic cell death of cardiac myocytes","volume":"112","author":"Dhingra","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12012-017-9412-4","article-title":"Exercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control Signaling","volume":"18","author":"Marques-Aleixo","year":"2018","journal-title":"Cardiovasc Toxicol."},{"key":"10.1016\/j.biopha.2025.118315_bib127","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1152\/ajpendo.00044.2013","article-title":"Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice","volume":"305","author":"Dolinsky","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118315_bib128","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","article-title":"Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism","volume":"73","author":"Loboda","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2025.118315_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13040649","article-title":"Chlorogenic acid attenuates doxorubicin-induced oxidative stress and markers of apoptosis in cardiomyocytes via Nrf2\/HO-1 and dityrosine signaling","volume":"13","author":"Cicek","year":"2023","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1615\/JEnvironPatholToxicolOncol.2019029341","article-title":"Nrf2\/HO-1 mediated protective activity of genistein against doxorubicin-induced cardiac toxicity","volume":"38","author":"Chen","year":"2019","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.biopha.2025.118315_bib131","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/CMAR.S186696","article-title":"Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK\/NF-kB signaling pathways","volume":"11","author":"El-Agamy","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.biopha.2025.118315_bib132","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1385\/CT:5:3:257","article-title":"Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction","volume":"5","author":"Berthiaume","year":"2005","journal-title":"Cardiovasc Toxicol."},{"key":"10.1016\/j.biopha.2025.118315_bib133","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.CIR.91.1.10","article-title":"Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect","volume":"91","author":"Siveski-Iliskovic","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118315_bib134","first-page":"3572","article-title":"Adriamycin-induced modulation of host defenses in tumor-bearing mice","volume":"52","author":"Maccubbin","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.118315_bib135","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1042\/bj20020752","article-title":"Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide","volume":"367","author":"Wang","year":"2002","journal-title":"Biochem J."},{"key":"10.1016\/j.biopha.2025.118315_bib136","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00280-019-04019-6","article-title":"Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats","volume":"85","author":"Sheibani","year":"2020","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.biopha.2025.118315_bib137","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3892\/etm.2016.3518","article-title":"Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a","volume":"12","author":"Sun","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib138","doi-asserted-by":"crossref","DOI":"10.1186\/s40360-017-0184-z","article-title":"Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis","volume":"19","author":"Shaker","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2025.118315_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105882","article-title":"Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis","volume":"173","author":"Khuanjing","year":"2021","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.118315_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.802502","article-title":"Neuraminidase1 inhibitor protects against doxorubicin-induced cardiotoxicity via suppressing Drp1-dependent mitophagy","volume":"9","author":"Qin","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118315_bib141","article-title":"Mitochondrial amount determines doxorubicin-induced cardiotoxicity in cardiomyocytes","volume":"12","author":"Xiong","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.biopha.2025.118315_bib142","doi-asserted-by":"crossref","DOI":"10.5812\/ijpr-146033","article-title":"Mitochondrial transplantation alleviates doxorubicin-induced toxicity in rat renal cells","volume":"23","author":"Seydi","year":"2024","journal-title":"Iran. J. Pharm. Res"},{"key":"10.1016\/j.biopha.2025.118315_bib143","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.ymthe.2023.02.016","article-title":"Delivery of mitochondria confers cardioprotection through mitochondria replenishment and metabolic compliance","volume":"31","author":"Zhang","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2025.118315_bib144","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22612","article-title":"The effects of mesenchymal stem cell mitochondrial transplantation on doxorubicin-mediated nephrotoxicity in rats","volume":"35","author":"Kubat","year":"2021","journal-title":"J. Biochem Mol. Toxicol."},{"key":"10.1016\/j.biopha.2025.118315_bib145","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-02878-3","article-title":"Mitochondrial transplantation therapy for ischemia reperfusion injury: a systematic review of animal and human studies","volume":"19","author":"Hayashida","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib146","article-title":"Therapeutic mitochondrial transplantation","volume":"27","author":"McCully","year":"2022","journal-title":"Curr. Opin. Physiol."},{"key":"10.1016\/j.biopha.2025.118315_bib147","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mito.2017.03.004","article-title":"Mitochondrial transplantation: From animal models to clinical use in humans","volume":"34","author":"McCully","year":"2017","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biopha.2025.118315_bib148","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jtcvs.2023.05.010","article-title":"Mitochondrial transplantation preserves myocardial function and viability in pediatric and neonatal pig hearts donated after circulatory death","volume":"167","author":"Alemany","year":"2024","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.biopha.2025.118315_bib149","doi-asserted-by":"crossref","first-page":"H966","DOI":"10.1152\/ajpheart.00883.2012","article-title":"Transplantation of autologously derived mitochondria protects the heart from ischemia-reperfusion injury","volume":"304","author":"Masuzawa","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.118315_bib150","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17813-0","article-title":"Transit and integration of extracellular mitochondria in human heart cells","volume":"7","author":"Cowan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118315_bib151","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1161\/STROKEAHA.120.030152","article-title":"Placental Mitochondria Therapy for Cerebral Ischemia-Reperfusion Injury in Mice","volume":"51","author":"Nakamura","year":"2020","journal-title":"Stroke a J. Cereb. Circ."},{"key":"10.1016\/j.biopha.2025.118315_bib152","article-title":"Are mitochondria targets or contributors in immune-mediated disease?","volume":"2015","author":"Kesner","year":"2015","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.biopha.2025.118315_bib153","article-title":"Mitochondrial transplantation for therapeutic use","volume":"12","author":"McCully","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib154","article-title":"Melatonin alleviates cardiac ischemia-reperfusion injury through SIRT3-dependent regulation of oxidative stress and mitochondrial dynamics","volume":"65","author":"Zhou","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2025.118315_bib155","first-page":"11841","article-title":"Metformin ameliorates doxorubicin-induced cardiotoxicity via activation of the AMPK\/SIRT1\/PGC-1\u03b1 pathway","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118315_bib156","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020589","article-title":"Exosomal Micro-RNA-96 Derived From Bone Marrow Mesenchymal Stem Cells Inhibits Doxorubicin-Induced Myocardial Toxicity by Inhibiting the Rac1\/Nuclear Factor-\u03baB Signaling Pathway","volume":"10","author":"Lei","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2025.118315_bib157","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92988-1","article-title":"Genome-wide CRISPR\/Cas9 screening in human iPS derived cardiomyocytes uncovers novel mediators of doxorubicin cardiotoxicity","volume":"11","author":"Sapp","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118315_bib158","article-title":"Assessment of doxorubicin toxicity using human cardiac organoids","volume":"203","author":"Zhou","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118315_bib159","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCHEARTFAILURE.114.001180","article-title":"Sexual dimorphism of doxorubicin-mediated cardiotoxicity","volume":"8","author":"Moulin","year":"2015","journal-title":"Circulation Heart Failure"},{"key":"10.1016\/j.biopha.2025.118315_bib160","first-page":"112","article-title":"Cardiac comorbidities influence mitochondrial transplantation efficacy","volume":"7","author":"Sharma","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib161","first-page":"544","article-title":"Personalized medicine in mitochondrial therapeutics: Promise and challenges","volume":"27","author":"O'Brien","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biopha.2025.118315_bib162","first-page":"1139","article-title":"Linking mitochondrial dysfunction to cell health in humans","volume":"1859","author":"Picard","year":"2019","journal-title":"Biochim. Et. Biophys. Acta (BBA) Bioenerg."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T11:55:31Z","timestamp":1754654131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225005098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":162,"alternative-id":["S0753332225005098"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118315","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardioprotective strategies against doxorubicin-induced cardiotoxicity: A review from standard therapies to emerging mitochondrial transplantation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118315"}}